These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction]. Liu X; Sun L; Li Z; Gao Y; Hui R Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922 [TBL] [Abstract][Full Text] [Related]
43. High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients. Sumarjaya IDGD; Nadha IKB; Lestari AAW Vasc Health Risk Manag; 2020; 16():125-132. PubMed ID: 32308405 [TBL] [Abstract][Full Text] [Related]
44. Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria. Song KH; Ko SH; Kim HW; Ahn YB; Lee JM; Son HS; Yoon KH; Cha BY; Lee KW; Son HY Diabetes Care; 2005 Jul; 28(7):1718-23. PubMed ID: 15983325 [TBL] [Abstract][Full Text] [Related]
45. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study. Vengen IT; Dale AC; Wiseth R; Midthjell K; Videm V Atherosclerosis; 2009 Nov; 207(1):239-44. PubMed ID: 19409566 [TBL] [Abstract][Full Text] [Related]
46. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study. Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216 [TBL] [Abstract][Full Text] [Related]
47. Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease. Suzuki T; Futami-Suda S; Igari Y; Watanabe K; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H; Oba K Lipids Health Dis; 2013 Mar; 12():31. PubMed ID: 23496967 [TBL] [Abstract][Full Text] [Related]
48. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041 [TBL] [Abstract][Full Text] [Related]
49. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men. Seed M; Ayres KL; Humphries SE; Miller GJ Am J Med; 2001 Jan; 110(1):22-7. PubMed ID: 11152861 [TBL] [Abstract][Full Text] [Related]
50. Lipoprotein(a) is a risk factor for diabetic retinopathy in the elderly. Morisaki N; Yokote K; Tashiro J; Inadera H; Kobayashi J; Kanzaki T; Saito Y; Yoshida S J Am Geriatr Soc; 1994 Sep; 42(9):965-7. PubMed ID: 8064105 [TBL] [Abstract][Full Text] [Related]
52. Predictors of adverse long-term outcome in acute myocardial infarction patients undergoing primary percutaneous transluminal coronary angioplasty: with special reference to the admission concentration of lipoprotein (a). Igarashi Y; Aizawa Y; Satoh T; Konno T; Ojima K; Aizawa Y Circ J; 2003 Jul; 67(7):605-11. PubMed ID: 12845184 [TBL] [Abstract][Full Text] [Related]
53. Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error. Egger M; Smith GD; Pfluger D; Altpeter E; Elwood PC Atherosclerosis; 1999 Apr; 143(2):275-84. PubMed ID: 10217356 [TBL] [Abstract][Full Text] [Related]
54. Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. Miwa K; Nakagawa K; Yoshida N; Taguchi Y; Inoue H J Am Coll Cardiol; 2000 Apr; 35(5):1200-5. PubMed ID: 10758961 [TBL] [Abstract][Full Text] [Related]
55. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes]. Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242 [TBL] [Abstract][Full Text] [Related]
56. [Serum cholesterol levels and their relation to ischemic cardiopathy in patients with non-insulin-dependent diabetes]. Rodríguez-Morán M; Guerrero-Romero F Salud Publica Mex; 1997; 39(5):420-6. PubMed ID: 9424723 [TBL] [Abstract][Full Text] [Related]
57. Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events. Di Maio S; Lamina C; Coassin S; Forer L; Würzner R; Schönherr S; Kronenberg F J Intern Med; 2022 Jan; 291(1):101-107. PubMed ID: 34096654 [TBL] [Abstract][Full Text] [Related]
58. Contribution of Lp(a) to the occurrence of vascular diseases: correlation of several risk factors including diabetes mellitus. Kubo M; Takami S; Matsuzawa Y J Atheroscler Thromb; 1995; 2 Suppl 1():S22-5. PubMed ID: 9225226 [TBL] [Abstract][Full Text] [Related]
59. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients. Hernández C; Chacón P; García-Pascual L; Simó R Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891 [TBL] [Abstract][Full Text] [Related]
60. Lipoprotein [Lp(a)] and peripheral vascular disease. Tyrrell J; Cooke T; Reilly M; Colgan M; Moore D; Shanik DG; Bergin C; Feely J J Intern Med; 1992 Oct; 232(4):349-52. PubMed ID: 1402639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]